Section 39-9903 – APPLICABILITY.
39-9703 [39-9903]. APPLICABILITY. A health care practitioner who provides prenatal or postnatal care and who administers or requests administration of a prenatal or postnatal screening or diagnostic test that detects Down syndrome or receives a result from such test that indicates a high likelihood or the definite presence of Down syndrome shall deliver to the […]
Section 39-9904 – SUPPORT SHEET.
39-9704 [39-9904]. SUPPORT SHEET. (1) The department shall create an up-to-date, evidence-based support sheet about Down syndrome that has been reviewed by medical experts and the Idaho Down syndrome council. The support sheet shall be provided at the time of diagnosis or when an ultrasound or test detects a high likelihood of Down syndrome. The […]
Section 39-9404 – INVESTIGATIONAL DRUGS — RIGHT TO TRY AND PROVIDE.
39-9404. INVESTIGATIONAL DRUGS — RIGHT TO TRY AND PROVIDE. (1) An eligible patient may request, and a manufacturer may make available to an eligible patient under the supervision of the patient’s treating physician, the manufacturer’s investigational drug, biological product or device, which drug, product or device shall be clearly labeled as investigational; provided however, that […]
Section 39-9602 – DEFINITIONS.
39-9602. DEFINITIONS. [EFFECTIVE UNTIL JULY 1, 2023] As used in this chapter: (1) "Committee" means the maternal mortality review committee established by section 39-9603, Idaho Code. (2) "Department" means the state department of health and welfare. (3) "Maternal death" means the death of a woman from any cause during pregnancy or within one (1) year […]
Section 39-9405 – NO COVERAGE OBLIGATION.
39-9405. NO COVERAGE OBLIGATION. (1) This chapter does not expand the coverage required of an insurer under the laws of this state. (2) A health plan, third-party administrator or government agency may, but is not required to, provide coverage for the cost of an investigational drug, biological product or device or the cost of services […]
Section 39-9406 – HEIRS NOT LIABLE FOR TREATMENT DEBT.
39-9406. HEIRS NOT LIABLE FOR TREATMENT DEBT. If a patient dies while being treated by an investigational drug, biological product or device under the terms of this chapter, the patient’s heirs are not liable for any outstanding debt related to the treatment or lack of insurance due to the treatment. History: [(39-9406) 39-9306, added 2016, […]
Section 39-9407 – PROHIBITIONS.
39-9407. PROHIBITIONS. (1) A licensing board or disciplinary body of this state shall not revoke, fail to renew, suspend or take any action against a health care provider’s license based solely on the provider’s recommendations to an eligible patient regarding access to or treatment with an investigational drug, biological product or device as allowed under […]
Section 39-9408 – LIMITATIONS.
39-9408. LIMITATIONS. (1) This chapter does not create a private cause of action against a manufacturer of an investigational drug, biological product or device or against a physician or any other person or entity involved in the care of an eligible patient using an investigational drug, biological product or device for any harm done to […]
Section 39-9409 – MANDATORY COVERAGE NOT AFFECTED.
39-9409. MANDATORY COVERAGE NOT AFFECTED. This chapter does not affect any mandatory health care coverage for participation in clinical trials provided elsewhere by law. History: [(39-9409) 39-9309, added 2016, ch. 168, sec. 1, p. 468; am. and redesig. 2017, ch. 58, sec. 19, p. 116.]
Section 39-9501 – SHORT TITLE.
39-9501. SHORT TITLE. This act shall be known and may be cited as the "Abortion Complications Reporting Act." History: [39-9501, added 2018, ch. 225, sec. 1, p. 509.]